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Background: The HIV epidemic has greatly affected sub-Saharan Africa, with the highest prevalence in 
the world found in Swaziland. One in three pregnant women in Swaziland has HIV. One of the PMTCT 
strategies is primary prevention of HIV among women who are uninfected. Understanding the reasons 
why pregnant women continue to seroconvert is the key in meeting this strategy.   
Purpose: The purpose of this study is to determine the factors associated with seroconversion among 
pregnant women utilizing Raleigh Fitkin Memorial Hospital in 2012. 
Objectives: The objectives of this study are to: determine the proportion of HIV non-infected pregnant 
women who are retested for HIV during pregnancy; determine the gestational age at which pregnant 
women are retested for HIV; establish the proportion of women who were initially HIV non-infected and 
seroconverted during pregnancy; and establish the factors associated with seroconversion during 
pregnancy. 
Methods: An observational cross-sectional study design with both descriptive and analytic components 
was carried out at Raleigh Fitkin Memorial Hospital. Systematic sampling was used for the recruitment 
of 381 pregnant women who were initially HIV non-infected. An interviewer-administered questionnaire 
and chart review were used to collect demographic and clinical data. The data was analyzed using 
descriptive and analytic statistics.  
Results: The results of the study show that demographic factors such as age and educational level are 
associated with HIV seroconversion during pregnancy. The findings also highlight how partner factors 
play a role in HIV seroconversion.  The results indicate that sexual behaviours 333of the pregnant 
women contribute greatly to HIV seroconversion.    
Conclusion: Pregnant women continue to engage in risky sexual behaviours during pregnancy and there 
is need to strengthen counseling on preventive measures throughout the antenatal care period. There is 
also need for programs to explore possibility of providing antiretroviral drugs for pre-exposure 
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DEFINITION OF TERMS 
 
HIV non-infected - a person who shows no evidence of HIV infection on an antibody blood test. 
Living with HIV  -a person who has antibodies against HIV detected on a blood test. 
Retest   - is repeating the HIV test following no detection of HIV antibodies. 
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AHI  - Acute HIV infection 
ANC  - Antenatal Care 
ARV  - Antiretroviral 
α  - alpha 
β  - beta 
CCR5  - Cysteine-Cysteine Chemokine Receptor 5 
DHS  -Demographic and Health Survey  
HIV  - Human Immune Virus 
HSV2  - Herpes Simplex Virus 2 or Human Herpes Virus 2 
MDGs                  - Millennium Development Goals   
MTCT  - Mother-to-Child Transmission 
PMTCT  - Prevention of Mother-to-Child Transmission 
p24   - A component of the HIV particle capsid 
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STIs  - Sexually Transmitted Infections 
TDF  - Tenofovir Disoproxyl Fumarate 
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CHAPTER 1:  INTRODUCTION 
1.1Background of the study 
This dissertation presents an investigation of factors associated with Human Immunodeficiency Virus 
(HIV) seroconversion during pregnancy among women in Swaziland. The HIV epidemic has posed a big 
challenge in sub-Saharan Africa with two thirds of people living with HIV found in this region [1]. 
Swaziland’s HIV prevalence has been among the highest in the world. The antenatal HIV surveillance in 
2010 estimated prevalence among pregnant women to be 41% [2]. Previous studies have shown that 
women are greatly affected by the HIV epidemic because of gender inequalities which deprive them of 
negotiating power for safer sex, and because of poverty which also increases their vulnerability to HIV 
infection because of low socioeconomic status [3, 4]. In Uganda the HIV incidence is shown to be higher 
among pregnant women compared to their non-pregnant counterparts [5]. Various biological and 
behavioral factors that occur during pregnancy have been implicated as the causes of this high incidence 
[5, 6]. 
According to the Swaziland Demographic and Health Survey (SDHS) [7], the antenatal coverage in 
Swaziland is above 97% with 74% of pregnant women attending antenatal care (ANC) for at least four 
visits. The median gestational age at initial ANC is 20 weeks. Antenatal care therefore provides an 
opportunity to care for pregnant women living with HIV, and to implement interventions for the 
prevention of mother-to-child transmission (PMTCT). However, 5% of pregnant women in Swaziland, the 
highest percentage in the world, seroconvert during pregnancy [8]. 
1.2 Problem Statement 
Seroconversion during pregnancy is associated with high mother-to-child transmission of HIV. In the 
Zimbabwe Vitamin A for Mothers and Babies (ZVITAMBO) study [9], the transmission of HIV was high in 
children born to mothers who were initially HIV negative and seroconverted during pregnancy (35 
infants per 100 child years) compared to exposed babies whose mothers were diagnosed with HIV at 
initiation of ANC (9 infants per 100 child years). Acquiring HIV infection during pregnancy increases 
mother-to-child transmission because the acute HIV infection period is characterized by very high viral 
load, which facilitates transmission [10, 11]. Pregnant women are at higher risk of acquiring HIV 
compared to non-pregnant women because of hormonal changes during pregnancy which are a 
mechanism for efficient transmission of HIV [12].  
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 Pregnant women who are in discordant relationships, where the woman is non-infected and the 
partner is living with HIV, are at high risk of acquiring HIV through unprotected sex [13, 14].  
Behavioural factors can also explain the reasons why there is a greater risk of getting infected with HIV 
during pregnancy. In west Africa, previous studies have shown that during pregnancy and breastfeeding 
periods sexual activity decreases in women, with male partners engaging in risky sexual behaviours [6, 
15]. In contrast, sexual behaviors among pregnant and lactating women in southern Africa are less 
known. However, a recent study in Malawi by Keating et al. [16]showed that many pregnant women 
became less sexually active in the last trimester. This decrease in sexual activity can put pregnant 
women at risk where the partner is not able to abstain and engages in high risk sexual activity. 
Most women who seroconvert during pregnancy contribute greatly to the burden of mother-to-child 
transmission because most HIV antibody tests cannot detect antibodies during the window period. 
Standard serologic tests used in most developing countries for diagnosing HIV will not identify all 
infected pregnant women [10, 17]. Hence women who acquire HIV during pregnancy are not diagnosed 
as being infected, resulting in a high proportion of new infections in infants which could have been 
prevented if HIV had been detected early. 
The particular concern of this dissertation is women who start their pregnancy HIV free and are infected 
during pregnancy. The factors associated with the acquisition of new HIV infection during pregnancy 
needs to be known in order to implement intervention programs aimed at preventing seroconversion 
during pregnancy [8, 18]. 
1.3. Aim 
The research undertaken sought to determine factors associated with seroconversion during pregnancy 
among women delivering at Raleigh Fitkin Memorial Hospital in 2012. 
1.4. Objectives 
The objectives of this study were to: 
1. Determine the proportion of HIV negative pregnant women who are retested for HIV during 
pregnancy; 
2. Determine the gestational age at which pregnant women are retested for HIV; 
3. Establish the proportion of women who were HIV negative and seroconverted during 
pregnancy; and 
- 3 - 
 
4. Establish the factors associated with seroconversion during pregnancy. 
1.5. Significance of study 
Most studies have looked at factors associated with HIV seroconversion among lactating women [19-
21]. However, few studies have explored why women seroconvert during pregnancy, despite evidence 
showing that there is greatest risk of vertical transmission when women seroconvert during pregnancy. 
Studies have shown that many infants who are HIV infected acquired HIV from mothers initially found to 
be HIV negative in pregnancy [22-24, 23]]. Vertical transmission could have been prevented if the 
mother had remained non-infected. 
Kieffer et al. [8] has demonstrated high seroconversion rate during pregnancy in Swaziland. However, it 
is unclear what could be the factors contributing to the risk of acquiring HIV during pregnancy in 
Swaziland. Finding out the characteristics, behaviours and practices of the initially HIV negative pregnant 
women is very important. Having a better understanding of what happens whilst the women are 
pregnant can contribute to the development of interventions to avert much vertical transmission that 
occurs as a result of women seroconverting. One of the strategies for the PMTCT program in Swaziland 
is the prevention of primary HIV infection in pregnant women.  
1.6. Overview of the dissertation 
This chapter has provided the background to this dissertation, the problem statement and the aim and 
objectives of the dissertation. 
Chapter 2 presents the theoretical and empirical framework for the dissertation through a review of the 
literature on factors associated with HIV seroconversion during pregnancy, mother-to-child transmission 
and prevention of mother-to-child transmission of HIV. 
Chapter 3 describes the methods that were used in conducting this study. It describes the study site, 
study design, target population, sampling framework, data collection techniques, data instruments, data 
analysis process, and data storage. Furthermore, it details the ethical considerations underpinning this 
study. 
Chapter 4 reports on the results of the study. It summarizes the data using descriptive statistics. The 
outcomes of bivariate and multivariate analysis are presented. 
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Chapter 5 discusses the findings of the research study and provides conclusions which may be drawn 
from these results. It further highlights some of the implications of the findings and makes proposals for 
further research and for practice. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
This chapter presents a review of the literature on HIV seroconversion in pregnant women. The first part 
of the chapter describes the status of the HIV epidemic in Swaziland in the general population. HIV in 
pregnancy is discussed in the second part of the review. The third part discusses seroconversion, 
including factors associated with seroconversion as identified through the literature. The fourth part 
highlights mother-to-child transmission amongst women living with HIV at onset of pregnancy and those 
who seroconvert during pregnancy. Prevention of mother-to-child transmission is also discussed in this 
section. Lastly the conceptual framework guiding this study is described in detail. 
2.2 The status of the HIV epidemic in Swaziland 
Sub-Saharan Africa, including Swaziland, is greatly affected by the HIV epidemic [1].  The National HIV 
prevalence survey shows that Swaziland has the highest HIV prevalence in the world, which is estimated 
to be 26% among men and women 15 to 49 years of age [7]. The way HIV impacts on women in sub-
Saharan Africa is disproportionate: in Swaziland female prevalence is 31% compared to 21% in males[1, 
7].  The Swaziland Demographic Health Survey (SDHS) [7] shows a variation in HIV prevalence by age and 
sex; prevalence is highest at 49% among women aged 25 to 29 years old and  at 45% in men aged 35 to 
39 years old. 
According to UNAIDS [1], more than half of the people living with HIV in the world are women. Earlier in 
the epidemic, in the early 80s,only 35% of women were infected [1]. The shift in the epidemic saw a 
greater proportion women infected compared to men as a result of heterosexual transmission. Rodrigo 
et al[25] reported the phenomenon of the feminization of HIV and highlighted the relationship between 
women, poverty and HIV. Most heterosexual infections are a result of multiple partners, either serial or 
concurrent. Intergenerational sex, which is very common in sub-Saharan Africa, has also been shown to 
be associated with an increase in risk of HIV acquisition in women. Other factors include socio-cultural 
factors such as gender norms which result in gender inequality [26]. As a result, women do not feel they 
have the liberty to choose partners and control sexual activity, including the negotiation of condom use 
[27]. Polygamy and wife inheritance are some of the cultural practices that put women at risk of getting 
HIV [28], including in Swaziland. 
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2.3 HIV in pregnancy  
The antenatal prevalence in Swaziland is estimated to be 41%, the highest among pregnant women in 
the world [29].  Despite the prevalence being high among pregnant women, the antenatal 
seroprevalence survey has shown that HIV has stabilized when compared to the previous ANC sentinel 
surveillance. The antenatal survey highlights that the prevalence of HIV among pregnant women is high 
in the 30-34 age group (54%) and low in the 15-19 age group (20%) [29].Approximately 13500 exposed 
infants are born in Swaziland annually and, without intervention, 15 infants will be infected each day, 
representing a transmission rate of 41% [30]. Most pediatric HIV infections are due to mother-to-child 
transmission (MTCT). Globally 390 000 new infections occur in children through vertical transmission 
and of these 360 000 are in sub-Saharan Africa [1]. Vertical transmission occurs mainly through three 
stages: in utero, during childbirth and during breastfeeding. The rates of MTCT differ in each stage: if 
there are no interventions, in utero the transmission rate is 5-10%, at childbirth it is 10-15% and during 
breastfeeding it is 10-15% [31]. When comparing the total rates of vertical transmission without 
intervention, it is approximately lower in developed countries, at 15-25% versus 25-35% in the 
developing countries [1]. 
One of the factors associated with MTCT is seroconversion during pregnancy. HIV seroconversion in sub-
Saharan Africa, including Swaziland, is higher among pregnant women compared to non-pregnant 
women. 
2.4 HIV seroconversion during pregnancy 
2.4.1 HIV seroconversion and pregnancy 
HIV seroconversion  and acute HIV infection (AHI) play a major role in MTCT of HIV.  AHI is the time from 
which a person acquires HIV until seroconversion, which is the early stages of HIV infection before the 
antibodies can be detected [32]. Studies  have shown that acute HIV infection in pregnancy increases 
the risk of MTCT of HIV. The timing of AHI during pregnancy also determines the chances of MTCT. 
Wertz et al. [33] highlight that perinatal transmission is greater when acute HIV infection occurs at time 
of delivery. This is because the HIV shedding into the cervicovaginal fluid is very high during the time of 
delivery as observed by Pilcher et al. [34]. 
2.4.2 Factors associated with HIV seroconversion during pregnancy 
In sub-Saharan Africa HIV seroconversion during pregnancy has ranged from 1.3 per 100 person years to 
5.2 per 100 person years [5, 21]. Being a woman is one of the factors associated with vulnerability to 
HIV, due to both biological and non-biological factors [25].  
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A biological disadvantage for women is pregnancy itself, as it can enhance the susceptibility of the 
female genital tract’s susceptibility to HIV [35]. The increased susceptibility could be due to the 
physiological, biological and behavioural differences that occur during pregnancy compared to non-
pregnant women. Hormonal changes that occur during pregnancy may make the pregnant woman more 
susceptible to HIV [12, 36, 37]. The high infectivity of the female genital tract with HIV might be due to 
elevated levels of primary endocervical receptors for HIV-1, CCR5, which are associated with a high 
progesterone state during pregnancy [38]. Previous studies have shown that there is increased HIV 
incidence during pregnancy [8, 30]. One study by Gray et al [5] showed that pregnant women were two 
times more likely to acquire HIV when compared to breast feeding women, non-breastfeeding women 
and non-pregnant women. However, the risk of getting HIV by pregnant women cannot be explained by 
biological factors alone. 
Studies have shown that there are certain sexual behaviours during pregnancy that increase the risk of 
getting HIVamongpregnant women. Serocoversionin pregnancy has been associated with mothers who 
have unprotected sex during  pregnancy [39]. Peltzer et al. [40] argue that behavioural factors such as 
unprotected sex and having multiple sexual partners during pregnancy contribute greatly to the risk of 
HIV acquisition. Being in a discordant relationship can also increase the risk of vertical transmission. If 
the woman is negative and the partner is positive this might increase the risk of getting HIV during 
pregnancy. In a study of HIV serodiscordant couples, Mugo et al. [14] observe that the risk of getting HIV 
was greatest during pregnancy. In Africa most discordant couples are pressured socially to conceive and 
they engage in unprotected sex, which is usually continued during pregnancy. Mugo et al. [14] argue 
that this may also increase the risk of HIV infection among pregnant women. There seems to be a need 
for male involvement and partner testing as shown by a study in Rwanda [41]. This is because male 
partners often use the woman’s test result as a proxy for their own status, and can increase the risk of 
the negative pregnant woman acquiring HIV. It appears that there is need to prevent primary HIV 
acquisition especially in couples who are discordant relationships using drugs for pre-exposure to HIV 
such as tenofovir disoproxyl fumarate (TDF) or TDF plus emtricitabine (TDF/FTC) as shown by current 
studies [42-44]. 
HIV seroconversion among pregnant women has been observed in women with history of sexually 
transmitted infections (STIs). STIs like Herpes Simplex Virus (HSV 2) have been shown to increase HIV 
acquisition. In one study, three out of five pregnant women who had seroconverted had chronic HSV2 
infection [17].  
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Changes in sexual activity can also put the pregnant women at risk of getting HIV.  A recent cross-
sectional study by Keating et al. [16] showed that sexual activity among pregnant women decreased as 
the gestational age increased. The researchers in this study used both questionnaire and in-depth-
interviews, which allowed greater comparison of sexual behaviours in early pregnancy, late pregnancy, 
during lactation and in non-pregnant women to learn more about the beliefs about abstinence during 
pregnancy. Different authors explain that the decrease in sex acts during pregnancy may be associated 
with increased partner risky behaviours [6, 15]. However, the recent study by Keating et al. [16] reports 
no difference in spouse’s risky behaviours, although some women in the study were afraid that the 
decrease in sexual activity during pregnancy could result in partner infidelity and HIV infection. Cultural 
beliefs seem to play a big role in abstinence during pregnancy and most women continue to follow this 
belief. However, some studies have shown that married women who reported that they practice 
abstinence were 3.2 times at risk of getting HIV compared to those who did not abstain [45]. Other 
researchers argue that these women acquire HIV despite them reporting abstinence because they are 
likely to continue having irregular unprotected sex [16].  
A study in Zimbabwe showed that the incidence of HIV among pregnant women was associated with the 
age of the woman, educational level and time of seroconversion [46]. Women, who are young, 
especially those less than 19 years, were more likely to seroconvert during pregnancy [21, 46, 47].  
Marital status is another factor that previous studies have highlighted; being married does not protect 
the women from acquiring new HIV infection. Polygamous relationships generally increase the risk of 
acquiring new infections especially among married women [48]. This could be due to the fact that there 
are many parties involved in the relationship, and if one partner gets infected everyone becomes at risk. 
2.5 Mother-to-child transmission of HIV 
2.5.1Timing of HIV infection and MTCT 
The timing of HIV acquisition plays a critical role in MTCT rates. Studies have been done to compare 
MTCT among women who were infected at onset of pregnancy and those that seroconvert during 
pregnancy. Gay et al. [17] argue that women who are infected in the third trimester have the highest 
risk of MTCT compared to women who acquired HIV before pregnancy or in the early trimesters.  The 
high levels of viral load during acute HIV infection have been associated with increased MTCT.  
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Various studies have been done to compare the transmission rate of HIV among women with different 
viral loads. John et al. [49] show that transmission rate was at  9% in women with viral loads less than 10 
000 copies/mL versus 45% for women with viral loads above 43 000 copies/mL.  When comparing the 
transmission rate of women who booked for their ANC already HIV positive and those that 
seroconverted during pregnancy, different authors produce varying results. In a study in Malawi, the 
mean viral load among women who seroconverted during pregnancy was very high: 1,324,766copies/mL 
compared to 35,537copies/mL that had tested HIV positive at first ANC visit [17]. However, a study by 
Rodongpisuthipong et al. [50] shows no difference in viral loads between women who seroconverted 
during pregnancy and those who had initial HIV positive results at first ANC visit. In this study there was 
similarity in mean viral loads among pregnant women who seroconverted and those who tested positive 
at initial ANC (17,505 and 20,845 copies/mL respectively). Both studies used a prospective cohort design 
to explore the association between pregnancy and acquisition of HIV and infant seroconversion. Both 
studies enrolled pregnant women who tested HIV positive and those who seroconverted during 
pregnancy. 
The outcomes of the pregnancies of women who seroconvert during pregnancy have been compared 
with those of women who had an initial HIV positive result at first ANC booking. A study by Birkhead et 
al. [51]shows that 22% of infants who tested HIV positive were born from mothers who had a negative 
HIV result at first antenatal visit and seroconverted during pregnancy  compared to 1.8% babies whose 
mothers booked for ANC already living with HIV.  Humphrey et al. [19], in the ZVITAMBO trial indicated 
that women who acquire infection during pregnancy are 4.6 times more likely to infect their infants as 
compared to women who were already living with HIV at the beginning of the trial. The high 
percentages of infants born from women who seroconvert during pregnancy might be due to the 
increased viral loads experienced during acute HIV infection when these mothers are not aware that 
their HIV status has changed.   
2.5.2 Prevention of Mother to Child Transmission of HIV (PMTCT) 
Vertical transmission of HIV is preventable. The goal of PMTCT programs is to eliminate pediatric 
infections. The World Health Organization (WHO) [52] recommended a four pronged strategy for PMTCT 
so as to prevent pediatric HIV infections and ensure the survival of both the mother and infant. Prong 
one: prevention of HIV infection among young women and pregnant women. Prong two: prevention of 
unintended pregnancies among HIV positive women. 
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 Prong three: prevention of HIV from HIV positive women to their infants. Prong four: provision of 
treatment, care and support to HIV infected women, their children and spouses. 
Most of the focus of PMTCT programs has been on prong three, that is the women who are living with 
HIV at onset of pregnancy. These women are given antiretroviral prophylaxis which includes zidovudine 
and intrapartum drugs and infant nevirapine [30]. Women who seroconvert during pregnancy might not 
access the PMTCT interventions because it is difficult to diagnose AHI. The tests that are used in 
developing countries, Swaziland included, cannot easily identify AHI. During the window period, HIV 
antibodies are at low levels and hence cannot be detected using standard antibody test kits. To diagnose 
AHI in pregnant women with negative antibodies for HIV, sophisticated tests are required that will be 
able to detect HIV Ribonucleic Acid (RNA) or p24. Birkhead et al. [51] show that women who 
seroconverted during pregnancy were less likely to receive intrapartum antiretroviral (ARV) drugs 
(80.5%) compared to women who were already living with HIV prior to pregnancy (10.5%).   
Preventing HIV among young women and reducing the incidence of HIV during pregnancy is the key to 
lowering the vertical transmission rates of HIV [53]. If there is no HIV infection to start with there will be 
no MTCT. Health education of the women on HIV testing is very important so as to prevent HIV 
incidence in pregnant women thus reducing vertical transmission of HIV [54]. Mofenson [53] highlights 
the importance of retesting especially at delivery and postnatal period for the early diagnosis of women 
with acute HIV infection. Retesting on its own may not be enough. Strategies are needed to address the 
issue of seroconversion. The PMTCT programs should have strategies to prevent new infections among 
pregnant women [48]. 
2.6 Conceptual framework 
There are many factors associated with HIV seroconversion during pregnancy, as presented in the 
previous section. These factors may be organized into demographic, socio-economic, cultural, health 
and health seeking behaviours. The proximate determinant framework proposed by McCarthy and 
Maine [55] provides an approach to organizing these factors and the influence they have on each other 
and on pregnancy, HIV exposure and HIV seroconversion during pregnancy, as shown in Figure 2.1.The 
original proximate determinant framework proposed by McCarthy and Maine states that it is possible to 
identify proximate and distant factors which result in either maternal mortality or morbidity. This 
framework is suitable for adaptation in this study since there are proximate and distant factors that are 
associated with exposure or non-exposure to HIV, which lead to infection or non-infection and 
seroconversion during pregnancy.  
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In this study the distant factors include socio-cultural, economic and demographic factors. Socio-cultural 
factors include cultural beliefs that influence sexual activity during pregnancy as shown by Keating et 
al.[16].Socio-cultural expectations for children may influence the discordant couples to engage in 
unprotected sex [14].Economic factors, including poverty, may predispose a woman to HIV because 
women might engage in risky behaviours such as transactional sex and polygamous relationships [25, 
56]. Age, marital status and educational level are some of the predictor demographic factors identified 
by various authors [21, 46, 48]. These distant factors on their own do not lead to risk taking behaviours 
but operate through proximate factors that may reduce or increase the risk of HIV infection. 
The proximate determinants include health and reproductive factors, access to health facility and 
utilization of health services by individuals. Reproductive factors such as parity and gravidity have been 
shown to be one of the factors associated with HIV seroconversion. Health or biological factors in this 
study include sexually transmitted infections, use of vaginal herbs and male circumcision as shown by 
other researchers [17, 46]. Behavioural factors, which are considered risky, include multiple partners 
and nonuse of condoms. The proximate factors interact with each other to create conditions for HIV 
exposure and infection leading to seroconversion during pregnancy.  
































Figure 2.1 Proximate and distant factors conceptual framework for HIV seroconversion 
in pregnancy 
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2.7 Summary 
The literature review has shown the role of acute HIV infection in MTCT rates. High viral load during the 
acute HIV infection period is the strongest risk factor for MTCT. Various factors such as socio-cultural, 
economic, demographic and health behaviours have been shown to be associated with HIV 
seroconversion. A conceptual framework of distant and proximate factors associated with HIV 
seroconversion during pregnancy was used to better understand how these factors interact leading in 
HIV seroconversion. 
  
- 13 - 
 
CHAPTER 3: METHODOLOGY 
3.1 Introduction 
This chapter describes in detail the methods used to collect and analyze data so as to achieve the aim 
and objectives of the study. The aim of this research was to determine the factors associated with HIV 
seroconversion during pregnancy among women delivering at Raleigh Fitkin Memorial Hospital in 2012. 
The specific objectives were to:  determine the proportion of HIV negative pregnant women who are 
retested for HIV during pregnancy; determine the gestational age at which pregnant women are 
retested for HIV; establish the proportion of women who were HIV negative and seroconverted during 
pregnancy; and establish the factors associated with seroconversion during pregnancy. This chapter will 
explain the study setting, study design, target population, sampling framework, the data collection, 
storage, and analysis.  The ethical considerations in conducting the study will also be presented. 
3.2 Study location 
The study was conducted in Manzini, at the Raleigh Fitkin Memorial (RFM) Hospital maternity ward. The 
major reason why RFM was chosen as a study location for this study is because of its central location, 
which makes the hospital accessible to pregnant women from all the four regions of the country. In 
Swaziland approximately 33 000 deliveries occur annually and 74% of women are reported to deliver in 
health facilities. Of the 33 000 deliveries that occur annually in Swaziland approximately 23% occur at 
Raleigh Fitkin Memorial Hospital.  
3.3 Study period 
The study participants were recruited from the maternity ward at the RFM Hospital, post-delivery, over 
a period of three months from April to July 2012.  
3.4 Study design 
The study design used was observational with descriptive and analytic cross-sectional components. The 
selected study design enabled the examination of the relationship between exposure and outcome 
variables. A cross-sectional study design was chosen for this study because of its advantages of being 
easy and cheap to conduct compared to cohort study designs that were used in similar studies [50, 57]. 
However, when compared to cohort study designs which were undertaken by other researchers, a cross-
sectional study design provides weaker evidence when it comes to determining causation of disease 
[58].  
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3.5 Study population 
3.5.1Target Population 
The target population was all women who initiate ANC HIV negative in Swaziland.   
3.5.2. Study population 
The study population was all women delivering at RFM Hospital, who had a record of testing negative 
for HIV at initiation of ANC. The reason for using women who had tested negative for HIV at first ANC 
was to help differentiate women who seroconverted from women who were previously sero-positive 
prior to antenatal care. The first HIV negative test during pregnancy was also used in previous studies as 
the baseline [17, 19].Using this unit of analysis allowed comparison of the results of this research with 
previous studies that have been conducted. 
3.5.2.1 Inclusion criteria 
All pregnant women who delivered at RFM Hospital and who had a record of an HIV negative result at 
initiation of antenatal care were included in the study. 
3.5.2.2Exclusion criteria 
The following pregnant women were excluded from the study: 
• All pregnant women who were living with HIV before initiation of ANC; 
• All pregnant women who tested HIV positive at initiation of ANC; and 
• All pregnant women who were never tested for HIV during ANC.  
3.6 Sampling size and strategy 
3.6.1 Sampling size 
The sample size comprised a representative proportion calculated from the number of women who 
deliver at RFM Hospital. The sample size was calculated using Stata version 11 based on the following 
assumptions: 
α -0.05 
β - 0.80 
Minimal clinical difference- 10% 
Seroconversion rate- 5% 
The total number of annual deliveries at RFM Hospital in 2010 was 7751.  Thus, a sample size of 381 
pregnant women was deemed sufficient for fulfilling the objectives of the study.  
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3.6.2 Sampling strategy 
The average monthly deliveries conducted at RFM hospital maternity in 2010 was 645, hence the 
sampling strategy used in this study was systematic random sampling. The advantage of systematic 
random sampling is that one does not need to know the complete population in order to do 
sampling[58]. The first pregnant woman was selected randomly from the delivery register. Each third 
woman after the starting point was selected into the study until the required sample size was reached. 
The pregnant women were recruited post-delivery from the maternity ward instead of ANC because 
most pregnant women initiate ANC late in pregnancy. According to the SDHS [7] the median number of 
weeks at first booking is twenty weeks. The SDHS states that, “A large proportion of the women 
continue to delay the initiation of antenatal care.” This makes it difficult for all women to be retested 
during the antenatal period. Furthermore, recruiting from the maternity ward makes it easier to identify 
the HIV status of the women post-delivery and permits a complete picture of what happened to the 
woman during ANC, intrapartum and postpartum periods. 
3.7 Data collection 
3.7.1 Variables 
The following variables in Table 3.1 below were collected, as guided by the conceptual framework. 
Table 3.1 List of variables for the study 
Dependent 
variables 








Demographic variables: Age 
marital status, educational level 
 
Social, economic and cultural variables: Income, 
history of sexual abuse, use of vaginal herbs 
 
Health and reproductive variables:  Parity, history of 
multiple partners, age at sexual debut, condom use 
during pregnancy, presence of syphilis in the 
pregnant woman, knowledge on HIV, 
 
Access to and utilization of health services variables: 
Number of antenatal care visits, gestational age at 
first booking, gestational age at retest 
 
Interviews with study 
participants and review of 
participants’ antenatal care 
cards and labour records. 
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3.7.2 Data collection techniques 
This study used two techniques to collect data: (i) by conducting structured interviews with women 
post-delivery and (ii) by undertaking a review of study participants’ labour records, which also 
comprised the ANC card. The following section will describe each technique in detail, highlighting the 
major strengths and weaknesses of each method. 
3.7.2.1 Structured interviews 
The structured interviews with the pregnant women were a very valuable data source for this study. 
During the interviews, the interviewer used a structured questionnaire to avoid misinterpretation of the 
questions and to minimize variability. The guiding principle behind the development of the 
questionnaire was the conceptual framework. The variables that were collected during the interview 
were based on the study objectives using a combination of questions. The questionnaire was 
interviewer administered as opposed to self-administered because face-to-face interview with the 
respondent helps to facilitate response and yields quality data. However, interviews are time consuming 
and costly to conduct [58]. 
3.7.2.2 Review of records 
Review of records was undertaken to complement the information gathered from the interview. The 
study participants’ ANC cards and labor records were reviewed to extract additional data. The data that 
was collected from reviewing the records include HIV status of participants, reproductive factors such as 
gestational age, parity, gravidity, history of STIs and retest for HIV. The data extraction tool was 
developed in a way that data could be collected so as to achieve the objectives. Reviewing records has 
its own strengths, which include the fact that the information obtained from the records cannot be 
influenced by the study. Incompleteness of the records is one limitation of this method of data 
collection [58]. However, most of the variables collected for this study are also key in the management 
of the pregnant woman hence they were available in the participant records. 
3.7.3 Data instruments 
The instruments that were used to collect data included an interviewer-administered questionnaire and 
a data extraction tool to extract data from the participant’s ANC card (Appendices A and B respectively). 
3.7.4 Data collection process 
A pilot study was conducted at Mbabane Government Hospital prior to the commencement of the study 
to test the data collection instruments. A sample of 34 women was systematically recruited and 
interviewed. The first pregnant woman was randomly selected and every third woman who fitted the 
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inclusion criteria was recruited into the pilot. The principal investigator conducted the pilot study. 
Conducting the pilot study assisted the principal investigator on how to phrase some of the questions 
for them to be better understood by the participants. The pilot also assisted in editing the questionnaire 
especially in the flow of the questions. Conducting the pilot helped in establishing the best suitable 
times to collect the data. 
The principal investigator and nurses attending deliveries at the RFM hospital conducted the main study. 
The first step for the principal investigator was to train the nurses who were going to collect data. The 
nurses were trained on the purpose of the study, data collection processes, the data collection tools, 
how to ensure reliability of data, and how to obtain informed consent. The principal investigator and 
nurses attending to clients delivering at the hospital administered the interviews. The interviews were 
conducted eight hours after the woman had delivered. The interviews and the data review lasted 
between 30-45 minutes. The interviews were conducted in the language the participant understood. 
The majority of the interviews were conducted in SiSwati. 
3.7.5 Ensuring validity and reliability 
The study was vulnerable to selection bias, as women who deliver at home might have different 
characteristics than those who deliver in hospital. Women who choose not to deliver at RFM hospital 
might also be different from those that do. 
In this study using structured interviews, whereby the interviewers asked the questions in a standard 
manner, with similar probes and elaborations for each respondent, ensured the reliability of the data. 
The responses that the respondents gave were recorded in the questionnaire by the interviewers in a 
similar way by means of offering options to select from. By administering a standardized questionnaire, 
reliability of the data was increased.   
Validity of data especially information bias, was limited by asking questions exploring similar issues 
differently. The principal investigator conducted an intensive training of the interviewers and this 
reduced interviewer variation during the interviews. Periodic checks were done also by the principal 
investigator on the questionnaires completed by the interviewers and showed them how to deal with 
errors seen. 
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3.7.6 Data management and storage 
i. Data quality - Double entry of data was done to ensure that there were no errors in data entry. 
Data was entered into two different excel spreadsheets and compared for discrepancies. 
Differences in the entries were resolved by checking the questionnaires. 
ii. Data safety - Electronic databases were password protected and the raw data was kept in a 
lockable cabinet at Elizabeth Glaser Pediatric AIDS Foundation offices, which are protected by a 
pin-coded alarm. The principal investigator kept the cabinet keys. 
iii. Data storage- Backup of data in hard drives and compact discs was done regularly. 
3.7.7 Data analysis 
i. Data was analyzed using SPSS software version 20 (SPSS Inc). 
ii. Data was summarized using descriptive statistics. Categorical data was summarized using 
frequency distributions. Exploratory analyses were done for ordinal categorical variables so as to 
know which summary statistics to use. Symmetrical data was summarized using mean, mode and 
standard deviation. Asymmetrical data was summarized using median and inter-quartile range. 
iii.Bivariate and multivariate analysis was done. Variables were manipulated in order to perform the 
appropriate regression analysis. The reference points used in the bivariate analysis were guided 
by literature. 
3.8 Ethical considerations 
The basic principles of ethics: autonomy, beneficence, non-maleficence and justice were supported in 
this study. Ethics approval was provided by the University of KwaZulu-Natal Biomedical Research Ethics 
Committee, BREC reference number BE 120/11 and the Swaziland Ethics Committee, reference number 
MH/599C).Permission was sought from the RFM hospital administration to conduct the study at the 
health facility. The study participants were granted the opportunity to refuse or withdraw from the 
study. Prior to participation in the study, the participants were requested to provide written informed 
consent (refer to Appendices F and G). To ensure confidentiality no names of participants were written 
on the questionnaire; a study number was assigned to each participant.   
  
- 19 - 
 
CHAPTER 4: RESULTS 
4.1 Introduction 
The aim of this study was to investigate the factors associated with HIV seroconversion during 
pregnancy in women recruited at RFM hospital, in Manzini. This chapter presents the data collected 
from women post-delivery in the maternity department at RFM hospital. Three hundred and eighty one 
women were recruited into the study between April and July 2012. Descriptive results with regard to the 
demographic characteristics, sexual behaviours, partner factors, reproductive factors and knowledge on 
HIV will be presented in this chapter. Statistical analysis was used to determine which factors, were 
associated with HIV seroconversion during pregnancy. 
4.2 Sample realization 
Three hundred and eighty one women were interviewed for the study, of which three had inconclusive 
results at second HIV test (n=3) and hence were excluded from the analysis. The final sample for analysis 
comprised three hundred and seventy eight (N=378) women. Of the 378 women included in the analysis 
9.7% seroconverted (n=37) and 90.2% (n=341) remained HIV uninfected.  
4.3 Demographics characteristics 
Table 4.1shows the demographic characteristics of study participants, comparing seroconvertors and 
non-seroconvertors. The mean age for the women was the same between the two groups (22 years 
p=0.85).A greater percentage of the participants were below the age of 30 years in both groups as 
shown in Table 4.1. With regard to marital status, the women fell into three main groups: married (30%), 
never married (58%) and cohabiting (11.1%). However, among those who were married a small 
percentage (7%) was in a polygamous relationship. The majority of women had attained an education 
level greater than primary schooling. More than half (63%) of the women reported that they were 
unemployed. Fewer women reported family income greater than 3000 Emalangeni per month 
(equivalent to 333 USD). 
Compared to women 30 years or older, women in the 20 to 23 years category and those in the 24 to 29 
years were 2.4 times and 1.78 times respectively at risk of seroconversion during pregnancy though not 
statistically significant. Individuals who were in polygamous relationships were 2.88 times more likely to 
seroconvert than those who were in monogamous relationships. However, this was not statistically 
significant (p=0.26).  
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Table 4.1 Clinical characteristics of study participants by seroconversion status (N=378) 
*Statistically significant at p-value of <0.05. 
Bivariate analysis showed statistically significant associations in two demographic characteristics as 
shown in Table 4.1: level of education (p=0.002) and income levels (p=0.046). The risk of seroconversion 
was higher in those with a lower level of education, and there was a trend towards decreasing risk of 
















16-19 4 (10.8) 89 (26.1) 0.66 (0.14-3.08) 0.60 
20-23 18 (48.6) 110 (32.3) 2.40 (0.67-8.56) 0.18 
24-29 12 (32.4) 98 (28.7) 1.78 (0.48-6.68) 0.38 
≥30  3 (8.1) 44 (12.9) REF  
Mean  22 22  0.85 
Marital status  Married  13 (35.1) 101 (29.6) REF  
Never married 20 (54.1) 200 (58.7) 0.78 (0.37-1.63) 0.50 
Separated 0 2 (0.6) 0 1 
Divorced 0 0   
Widowed 0 0   
Cohabiting 
 
4 (10.8) 38 (11.1) 0.82 (0.25-2.66) 0.74 
Polygamous 
marriages 
Yes 2 (15.4) 6 (5.9) 2.88 (0.52-16.04) 0.23 
No   11 (84.6) 95 (94.1) REF  
Level of 
education 
None to Some 
primary 
8 (21.6) 18 (5.3) 7.85 (1.88-32.83) 0.005* 
Completed 
primary 
8 (21.6) 33 (9.7) 4.28 (1.06-17.3) 0.041* 
Some 
secondary 
11 (29.7) 123 (36.1) 1.58 (0.42-5.89) 0.50 
Completed 
secondary 
7 (18.9) 114 (33.4) 1.09 (0.27-4.36) 0.91 
Tertiary  3 (8.1) 53 (15.5) REF  
Source of 
Income 
Unemployed 26 (70.3) 211 (61.9) 1.29 (0.29-5.84) 0.74 
Student 0 22 (6.5) 0.000 1 
Formal skilled  2 (5.4) 21 (6.2) REF  
Formal 
unskilled 
2 (5.4) 34 (10.0) 0.62 (0.81-4.72) 0.64 
Self employed 7 (18.9) 53 (15.5) 1.39 (0.27-7.23) 0.70 
Income level None 11 (29.7) 114 (33.4) 2.48 (0.67-9.17) 0.17 
Less than 
E1000 
13 (35.1) 84 (24.6) 3.97 (1.10-14.47) 0.037* 
E1000-E3000 10 (27.0) 66 (19.4) 3.89 (1.03-14.73) 0.046* 
≥ E3000 3 (8.1) 77 (22.6)  REF  
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In the multivariate logistic regression analysis, level of education retained statistical significance as 
shown in Table 4.2. Age was not statistically significant in the bivariate analysis and assumed borderline 
significance (p= 0.067) in the logistic regression. 
Table 4.2 Logistic regression on the demographic characteristics 




Marital status 0.84 
Polygamous relationship 0.23 
Level of education* 0.002 
Source of income 0.20 
Income level 0.119 
*Statistically significant in the bivariate analysis 
4.4 Partner factors 
This study assessed several partner factors, as shown in Table 4.3 below, including: level of education, 
circumcision status, reported faithfulness, reported HIV status, frequency of travelling, and having 
discussed HIV issues in the relationship.  
A high percentage of seroconvertors, 62.2% versus 23.5% non-seroconverters, reported that their 
partners were frequent travelers. It is evident from Table 4.3 that most partners who travelled did so 
once a month in both groups. Women with partners who were frequent travelers were associated with 
increased risk of seroconversion during pregnancy (p<0.001). There is a trend towards an increase in risk 
of seroconversion as the frequency of travel increases.  Reviewing the time spent away by partner, a 
trend is again seen towards an increase in risk of seroconversion during pregnancy as the partner’s 
length of travel increases. Women who reported that their partners were away for several months at a 
time were 11.5 times at risk of getting HIV during pregnancy (p= 0.026) compared to those who 
reported that their partners travelled for a few days. 
Almost all (94%) of the women in the study reported that their partners had completed secondary and 
tertiary education. Low partner education was associated with increased risk of seroconversion during 
pregnancy. Women whose partners had no education or some primary school education were 11.1 
times more likely to seroconvert versus those with higher education (p=<0.001). There is a trend 
towards increase in risk of seroconversion of mothers during pregnancy as the partner level of 
education decreases. 
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More than two thirds of the women in both groups had partners who were not circumcised. Partner 
circumcision status, as shown in Table 4.3 is a protective factor. However, statistical significance was not 
established in this study (p=0.20).  
When it came to discussing HIV issues in the relationship, a high percentage (87%) of the women 
reported that they did talk about HIV with their partners. In relationships where the women and their 
partners did not talk about HIV issues, they were 2.48 times more likely to seroconvert during 
pregnancy. Also the association between discussion of HIV issues in the relationships and 
seroconversion was statistically significant (p=0.03). 
Despite the high proportion of women reporting that they have discussed HIV issues with their partners, 
amongst seroconvertors 73%reported that their partners had not tested or they did not know if their 
partners had tested. The risk of seroconversion during pregnancy was greatest among women who 
reported not knowing the HIV status of their partners (p= < 0.001). 
Interestingly, more than 50% of the women who seroconverted perceived that their partner was either 
not faithful or they doubted the faithfulness. There was a statistically significant association between 
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 Table 4.3 Partner characteristics 
Categorical 














Frequent traveler Yes 23(62.2) 80(23.5) 5.33(2.63-10.86) <0.001* 
No    14(37.8) 260(76.5) REF  





3(13.0) 28(34.6) REF  
Once a 
month 
14(60.9) 40(49.4) 3.27 (0.86-12.44) 0.08 
Every three 
months 
5(21.7) 12(14.8) 3.89(0.80-18.94) 0.09 
Every six 
months 
1(4.3) 1(1.2) 9.33(0.46-190.63) 0.14 
Once a year 0 0   
Length of travel A few days  3(13) 23(28.4) REF  
A week 7(30.4) 27(33.3) 1.98(0.46-8.58) 0.36 
A month 10(43.5) 29(35.8) 2.64(0.65-10.74) 0.17 
Some 
months 
3(13) 2(2.5) 11.5(1.33-99.33) 0.026 
Level of education None to 
Some 
primary 
4(10.8) 7(2.1) 11.10(2.62-47.06) <0.001* 
Completed 
primary 
4(10.8) 9(2.6) 8.64(2.13-35.07) 0.003* 
Some 
secondary 
12(32.4) 70(20.5) 3.33(1.25-8.84) 0.016* 
Completed 
secondary 
10(27) 119(34.9) 1.63(0.63-4.42) 0.34 
Tertiary     7(18.9) 136(39.9) REF  
Circumcision Yes     7(18.9) 30(81.1) REF  
No  96(28.4) 242(71.6) 0.59(0.25-1.38) 0.22 
Discuss HIV issues Yes    28(75.7) 301(88.5) REF  
No 9(24.3) 39(11.5) 2.48 (1.09-5.64) 0.03 
Partner HIV status 
as reported by 
women 
Infected 1(2.7) 5(1.5) 5.2(0.55-49.23) 0.15 
Uninfected     9(24.3) 234(68.6) REF  




Yes  16(43.2) 235(69.1) REF  
No 11(29.7) 22(6.5) 0.14(0.056-0.33) <0.001* 
Unknown 10(27) 83(24.4) 0.24(0.091-0.64) 0.004* 
*Statistically significant at p-value of 0.05. 
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In the logistic regression, several partner factors retained statistical significance, except for partner 
length of travel as shown in Table 4.4. The factors that retain significance include: partner being a 
frequent traveler, partner level of education, discussing HIV issues with partner, reported partner HIV 
status and perceived partner faithfulness.  




Frequent traveler* <0.001 
Frequency of travel 0.17 
Length of travel* 0.13 
Level of education* <0.001 
Circumcision 0.20 
Discuss HIV issues* 0.04 
Partner HIV status as reported by women* <0.001 
Partner faithfulness as reported by women* <0.001 
*Statistically significant in the bivariate analysis 
4.5 Sexual behaviour factors 
Table 4.5 shows the reported sexual behaviours of study participants. More than 50% of the participants 
reported having one sexual partner in the past 12 months. A majority of women in the study reported 
having two lifetime partners. A greater percentage (88%) of women who participated in the study had 
their sexual debut between 17and 20 years. The mean age for sexual debut was 17 years among 
seroconvertors versus 18 years in the non-seroconvertors. As revealed by Table 4.5, there was a trend 
towards decrease in risk of HIV seroconversion with increase in age of sexual debut. 
Condom usage at sexual debut was very low (27%) among seroconvertors and these women were 4.38 
times more likely to seroconvert during pregnancy than those who used condoms on sexual debut 
(<0.001). High numbers of women reported ever having used condoms in their sexual history. However, 
during pregnancy less than 25% of seroconvertors used condoms and notably none of them used 
condoms consistently. Worth noting is the number of women who reported that they abstained from 
sex during pregnancy, 2.7% and 7.3% among seroconvertors and non-seroconvertors respectively. 




- 25 - 
 
A few participants reported using vaginal herbs during pregnancy in both groups. There was no 
significant difference of sexual abuse between seroconvertors and non-seroconvertors. The women 
diagnosed with syphilis were 12 times more likely to seroconvert when compared to those who did not 
seroconvert (p=<0.001). More than 25% seroconvertors reported history of STI, compared to less than 
10% non-seroconvertors. 
In Table 4.5 the results of the bivariate analysis show that a number of sexual behaviours were 
associated with HIV seroconversion during pregnancy. There was a statistically significant association 
between having multiple partners in the past 12 months and HIV seroconversion during pregnancy 
(p=0.002). There was also a statistically significant association between number of lifetime partners and 
risk of HIV seroconversion during pregnancy (p=0.016). Sexual debut between14-16 years was 
statistically associated with increased risk of HIV seroconversion during pregnancy (p= 0.035). In 
addition, women whose sexual debut was without condoms and those who had unprotected sex during 
pregnancy experienced increased risk of seroconversion during pregnancy (p=<0.001). Furthermore, a 
reactive RPR test for syphilis and a history of STI were associated with HIV seroconversion during 
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No of sexual partners 
in the last 12 months 
1  28(75.7) 315(92.4) REF  
≥2 9(24.3) 26(7.6) 3.89(1.67-9.12) 0.002* 
Number of lifetime 
partners 
1 6(16.2) 126(37) REF  
2 18(48.6) 116(34) 3.26(1.25-8.49) 0.016* 
≥ 3 13(35.1) 99(29) 2.76(1.01-7.52) 0.047* 
      
Age of sexual debut 14-16 16(43.2) 54(15.8) 4.05(1.11-14.83) 0.035* 
17-20 18(48.6) 246(72.1) 1(0.28-3.55) 1 
≥ 20 3(8.1) 41(12) REF  
Mean 17 18   
      
Condom use sexual 
debut 
Yes 10(27) 211(61.9) REF  
No 27(73) 130(38.1) 4.38(2.05-9.35) <0.001* 
Ever used condoms 
in their lifetime 
Yes   34(91.9) 318(93.3) REF  
No 3(8.1) 23(6.7) 1.22(0.35-4.28) 0.76 
Condom use during 
pregnancy 
Yes  9(24.3) 185(54.3) REF  
No 27(73) 131(38.4) 4.24(1.93-9.31) <0.001* 
Abstinence 1(2.7) 25(7.3) 0.82(0.1-6.77) 0.86 
Frequency of 
condom use during 
pregnancy 
Always 0 82(43.6) REF  
Sometimes 10(100) 106(56.4) 152403257 1 
Different biological 
fathers of children 
Yes 10(35.7) 138(78) 6.37 (2.72-14.91) <0.001* 
No 18(64.3) 39(22) REF  
Use of vaginal herbs Yes 5(13.5) 41(12) 1.14(0.42-3.1) 0.79 
No  32(86.5) 300(88) REF  
History of sexual 
abuse 
Yes 1 (2.7) 11 (3.2) 0.83 (0.11-6.64) 0.86 
No  36 (97.3) 330 (96.8) REF  
Syphilis status Reactive 6(16.2) 5(1.5) 12.9(3.74-45.18) <0.001* 
Non-reactive   29(78.4) 314(92.1) REF  
Unknown 2(5.4) 22(6.5) 0.98(0.22-4.39) 0.98 
History of STI Yes 13(35.1) 25(7.3) 6.85(3.11-15.06) <0.001* 
No  24(64.9) 316(92.7) REF  
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With logistic regression all the sexual behaviours retained their significance as shown in Table 4.6 below. 
Table 4.6 Logistic regression on sexual behaviours of participants 
Variable LR Test (X
2
 Test) 
Number of sexual partners in the last 12 months* 0.004 
Number of lifetime partners * 0.027 
Age at sexual debut* 0.001 
Condom use at sexual debut* <0.001 
Condom use during pregnancy* <0.001 
Frequency of condom use during pregnancy 0.006 
Different biological fathers of children* <0.001 
Syphilis status* <0.001 
History of STIs* <0.001 
*Statistically significant in the bivariate analysis 
4.6 Risk of HIV infection 
Most women perceived themselves as not at risk of acquiring HIV during pregnancy after receiving the 
initial HIV result as shown in Table 4.7. Women selected different reasons for thinking they were risk-
free, as shown by Figure 4.1 below. The women could select more than one reason which made them 
perceive themselves as not at risk of acquiring HIV after the initial HIV negative result. The most 
common reason given by the women was having one sexual partner (63.2% seroconvertors and 62.7% 
non-seroconvertors). Partner faithfulness was the second most common reason selected by the women, 
with the third reason selected was ‘being married’. 
In the bivariate analysis, consistent use of condoms during pregnancy was a protective factor and its 
statistical significance was shown in the logistic regression analysis as shown in Table 4.7 below.  
 
 
Figure 4.1 Shows the percentage women giving a reason
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Table 4.7 Perceived risk of HIV infection 
Categorical 





















How do you rate 
your Risk of HIV 
No risk  1(33.3) 56(16.5) 0.17 REF  
Small risk 0 115(33.9)  0.00 1 
Moderate 
risk 
0 67(19.8)  0.00 1 
High Risk 1(33.3) 11(3.2)  5.09(0.29-87.68) 0.26 
 Don’t know 1(33.3) 90(26.5)  0.62 (0.04-10.15) 0.73 
Perception of risk 
after initial negative 
HIV test 
Yes 18(48.6) 134(39.3) 0.27 1.46(0.74-2.89) 0.27 
 No 19(51.4) 207(60.7)  REF  
Reasons for 
perception of ‘no 
risk 
      
Being married Yes 5 (26.4) 24 (11.5) 0.93 2.75 (0.911-8.32) 0.07 
 No  14 (73.7) 185 (88.5)  REF  
One sexual partner Yes 12 (63.2) 131 (62.7) 0.97 1.02 (0.39-2.70) 0.97 
 No  7 (36.8) 78 (37.3) REF   
Partner faithful 
 
Yes 7 (36.8) 109 (52.2) 0.20 0.53 (0.20-1.41) 0.21 
 No 12 (63.2) 100 (47.8)  REF  
Consistent use of 
condoms 
Yes 0 46 (22) 0.003 0.00 1 
 No 19 (100) 163 (78)  REF  
 
      
Partner circumcised Yes 2 (10.5) 6 (2.9) 0.15 3.98 (0.75-21.25) 0.11 
 No  17 (89.5) 203 (97.1)  REF  
Other reasons Yes 3(15.8) 31(14.8) 0.91 1.07(0.3-23.91) 0.91 
No 16(84.2) 178(85.2)  REF  
*Statistically significant at p-value of 0.05. 
4.7 Reproductive factors 
The reproductive factors associated with HIV seroconversion are presented in Table 4.8. More than half 
of all women had four or more antenatal care visits, 62.2% and 76% among HIV seroconvertors and non-
seroconvertors respectively. The number of women who were pregnant for the first time was 29.7% 
among seroconvertors versus 54.8% in the non-seroconvertors group. Women who were pregnant for 
the second time were more likely to be infected compared with women of higher gravida.  
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The mean gestational age at ANC booking was 21.5 weeks for HIV seroconvertors whereas that of non-
seroconvertors was 20 weeks. A high percentage (98%) of the women who participated in the study had 
an HIV test at first ANC visit. A large proportion (98%) of women had an HIV repeat test done during 
ANC. The mean gestational age at retest was 30 weeks among seroconvertors and 29 weeks among non-
seroconvertors. 
There was a statistically significant association between the number of pregnancies and HIV 
seroconversion during pregnancy. Compared to primigravida the risk of seroconversion was 3.48 times 
higher for women with two pregnancies (p=0.002). Interestingly, there was a trend towards increase in 
risk of HIV seroconversion during pregnancy as the gestational number of weeks at first ANC increased. 
The results show that parity was associated with HIV seroconversion during pregnancy (p=0.04).  
With logistic regression analysis, the number of pregnancies, gestational age at first ANC and parity 
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 ANC visits  <4 14(37.8) 82(24) 1.92(0.95-3.91) 0.071 
≥4  23(62.2) 259(76) REF 
 




Primigravida 11(29.7) 187(54.8) REF 
 
2 17(45.9) 83(24.3) 3.48(1.56-7.76) 0.002* 
 ≥2 9(24.3) 71(20.8) 2.16(0.86-5.42) 0.1 
Gestational age at 
first ANC 
<16  1(2.7) 67(19.6) REF 
 
16-25 27(73) 226(66.3) 8.00(1.07-60.0) 0.043* 
≥26   9(24.3) 48(14.1) 12.56(1.54-
102.48) 
0.018* 
 Mean 21.5 20 
  
HIV testing at first 
ANC 
Yes   36(97.3) 334(97.9) REF 
 
 No 1(2.7) 7(2.1) 1.33(0.16-11.08) 0.80 
Retest at ANC Yes   37(100) 335(98.2) REF 1 
 No 0 6(1.8) 
  
Gestational age at 
retest 
<30    REF 19 (51.4)  138 (41.2) 0.66(0.34-1.31) 0.24 
>30 18(48.8)  197 (58.8) 
  
 Mean 31 29 
  
Exit test at 32 to 
36 weeks 
Yes   20(57.1) 224(65.7) REF 
 
 No 15(42.9) 117(34.3) 1.44(0.71-2.91) 0.32 
Retest at Labour Yes 12(35.3) 89(26.1) REF 
 
 No 22(64.7) 252(73.9) 0.65(0.31-1.36) 0.25 
Parity 0   12 (32.4) 193 (56.6) REF 
 
1-2 23 (62.2) 125 (36.7) 2.96 (1.42-6.16) 0.04* 
≥3 2 (5.4) 23 (6.7) 1.40 (0.29-6.64) 0.67 
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Table 4.9 Logistic regression on reproductive factors of participants 
Variable LR Test (X
2
 Test) 
ANC visits* 0.078 
Number of pregnancies* 0.007 
Gestational age at first ANC * 0.02 
HIV testing at first ANC 0.80 
Retest at ANC 0.26 
Gestational age at retest 0.24 
Exit test at 32-36 weeks 0.32 
Retest at labour 0.26 
Parity * 0.011 
*Statistically significant in the bivariate analysis 
4.8 Knowledge on HIV 
Table 4.10 shows the various questions which were used to assess the knowledge on HIV and PMTCT of 
the study participants. The women were assessed on the signs and symptoms of HIV, MTCT, HIV 
seroconversion and HIV prevention. Most of the women were knowledgeable on all the areas assessed. 
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Table 4.10 Knowledge of HIV 

































Does a person with 
HIV always show 
Signs and symptoms  
Yes 1 (2.7) 9 (2.6) 0.90 1.01 (0.13-8.53) 0.97 
No 33 (89.2) 311 (91.2)  REF  
Don’t know 3 (8.1) 21 (6.2)  1.35 (0.38-4.76) 0.64 
Mother to child HIV 
transmission 
Yes  34 (91.9) 324 (95) 0.74 REF  
No 2 (5.4) 12 (3.5)  1.59 (0.34-7.39) 0.56 
Don’t know 1 (2.7) 5 (1.5)  1.91 (0.22-16.8) 0.56 
HIV seroconversion 
during pregnancy 
Yes     34 (91.9) 322 (94.4) 0.84 0.63 (0.07-5.42) 0.68 
No 1 (2.7) 6 (1.8)  REF  
Don’t know 2 (5.4) 13 (3.8)  0.92 (0.07-12.28) 0.95 
Healthy looking man 
HIV transmission 
Yes 36 (97.3) 314 (92.1) 0.23 REF  
No 0 13 (3.8)  0.00 1 
Don’t know 1 (2.7) 14 (4.1)  0.62 (0.08-4.88) 0.65 






36 (97.3) 325 (95.6) 0.48 REF  
At most 
encounters 
1 (2.7) 8 (2.4)  1.13 (0.14-9.28) 0.91 
At high risk 
encounters 
0 7 (2.1)  0.00 1 
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4.9 Multivariate analysis 
Multivariate analysis of all statistically significant variables using a multinomial logistic model showed 
that women with history of STI, women who reported not using condoms at sexual debut, women who 
reported having multiple sexual partners in the past 12 months and women who reported having a 
partner who was a frequent traveler were independently associated with acquiring HIV infection during 
pregnancy as shown in Table 4.11 below. 
4.10 Summary 
The results of the study show that demographic factors such as age (p=0.067) and educational level 
(p=0.002) are associated with HIV seroconversion during pregnancy in women who initially tested 
negative for HIV at initiation of ANC. The findings also highlight how the partner factors play a role in 
HIV seroconversion. The study findings show the following partner factors to be associated with HIV 
seroconversion among pregnant women: frequency of partner travel (p<0.001), level of partner 
education (p=<0.001), discussing HIV issues in the relationship (p=0.04), reported partner HIV status 
(p<0.001), and perceived partner faithfulness (p<0.001). The results of the study indicate that sexual 
behaviours of the women contribute greatly to HIV seroconversion and these include; multiple partners 
in the past 12 months (p=0.004), multiple partners in lifetime (p= 0.027), early sexual debut (p=0.001), 
condom use at sexual debut (p<0.001), condom use during pregnancy (p<0.001), different biological 
fathers of children (p<0.001), syphilis status (p<0.001), and history of STI (p<0.001).Women who had 
gravidity of two (p=0.002), booked for ANC at 16-25 weeks (p=0.043) and above 25 weeks (p=0.018) and 
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Table 4.11 Adjusted odds ratio for factors associated with HIV seroconversion 





Categories All data p-value 
Odds Ratio (95% CI) 
Level of education None to Some primary  0.058 (0- 10.65) 0.30 
Completed primary 0.051 (0- 7.61) 0.26 
Some secondary 0.024 (0- 4.72) 0.17 
Completed secondary 0.014 (0- 3.30) 0.12 
Tertiary  REF  
Discuss HIV issues Yes    REF  
No 1.54 (0.14- 16.89) 0.73 
Number of sexual partners in 
the last 12 months 
1  REF  
≥2 73.34 (3.05- 1764.2) 0.008* 
Number of life time partners 1 REF  
2 0.18 (0.019- 1.63) 0.13 
≥ 3 0.57 (0.033- 9.89) 0.70 
Age of sexual debut 14-16 3.26 (0.15- 66.96) 0.44 
17-20 2.99 (0.19- 47.32) 0.44 
≥ 20 REF  
Condom use at sexual debut Yes REF  
No 7.80 (1.36- 44.27) 0.021 
Condom use during pregnancy Yes  REF  
No 1.23E-9 (1.23E-9 to 1.3E-8) 1 
Abstinence 2.35E-25 (4.84E-10 to 1.14E-8) <0.001* 
Different biological fathers of 
children  
Yes 4.41 (0.52- 37.83) 0.18 
No REF  
Syphilis status Reactive 2.33E-25 (0 - 3.12E-23) 1 
Non-reactive   REF  
Unknown 0.65 (0.024- 17.28) 0.8 
History of STI Yes 12.55 (1.72- 91.66) 0.013* 
No  REF  
Number of pregnancies Primigravida   REF  
2 0.36 (0.058- 2.21) 0.27 
≥2 1.62E-6 (0 - 3.56E-5) 1 
Gestational age at first ANC <16  REF  
16-25 0.22 (0.019- 2.64) 0.18 
≥26   1.63E29 (0-  8.33E30) 1 
Parity 0   REF  
1-2 0.036 (0 - 5.76) 0.20 
≥3 71961.15 (0.001- 182856) 1 
Partner frequent traveller Yes    13.08 (2.0- 87.45) 0.008* 
No REF  
Partner Level of education None to Some primary 0.001 (2.08E-5 - 0.10) 0.003* 
Completed primary 0.044 (0.001 - 3.87) 0.17 
Some secondary 0.025 (0.001 - 0.44) 0.011 
Completed secondary 0.22 (0.026 - 1.96) 0.18 
Tertiary     REF  
- 36 - 
 
CHAPTER 5: DISCUSSION AND CONCLUSION 
In this chapter the results are discussed in relation to each other and in light of previous studies 
reported in the literature. The aim of this study was to determine factors associated with 
seroconversion during pregnancy among women delivering at Raleigh Fitkin Memorial Hospital in 2012. 
The results of this study show that there is seroconversion rate of 37/378 (9.7%) among pregnant 
women who had tested HIV negative at initial ANC booking. The seroconversion rate is higher than the 
5% found by Kieffer et al. [59] in Swaziland, the 3.9%  found in Nigeria [60],and the 1% in Lilongwe, 
Malawi [16]. This shows that HIV seroconversion rate among pregnant women varies between regions 
and countries [1]. 
The risk of HIV infection in pregnant women in Manzini region, Swaziland, was associated with distant 
and proximate factors. The significant distant factors included demographic determinants such as age, 
level of education, income and partner factors. The significant proximate factors comprised mainly 
reproductive and sexual behaviours. HIV seroconversion risk during pregnancy was independently 
associated with history of STI, not using condoms at sexual debut, multiple sexual partners in the past 12 
months and having a partner who was a frequent traveler. 
Demographic determinants are important components in the conceptual framework of factors 
associated with exposure or non-exposure to HIV, which lead to seroconversion during pregnancy. In 
regard to demographical factors, this study shows that women who had few years of education, were 
below the age of 24 years and had low income were at higher risk of acquiring HIV during pregnancy. 
Studies done in other African countries like Zimbabwe, Malawi and Tanzania also highlight that women 
with less education are more likely to seroconvert during pregnancy [17, 46, 61]. In contrast a study in 
Uganda reported high HIV incidence in pregnant women with higher levels of education and there was 
no interaction between education and HIV acquisition [5]. In the general population there are conflicting 
results on the effect of the level of education on HIV acquisition. Most researchers have noted a shift in 
HIV acquisition from more educated to least educated in the past decade [62-64]. De Walque et a 
l[63]concluded that the higher the level of education, the more likely is a change in sexual behavior.  
Hargreaves et al. [65]in South Africa reported that women and men with higher levels of education were 
less likely to acquire HIV because of higher reported condom usage. Contrary to these studies Msisha et 
al. [66] found no association between increasing education and HIV acquisition in both men and women. 
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Women with few years of education have a greater chance of acquiring HIV during pregnancy because 
they are more vulnerable economically compared to educated women [66]. It is well documented that 
low levels of education amongst women are associated with low income and financial dependence on 
men [68-70].In this study low income was indeed associated with increased risk of HIV seroconversion. 
The results of this study differ to previous studies reporting higher HIV prevalence among wealthy 
women compared to poor women [71].However, the results of this study concur with those of a study 
done in Zimbabwe, where HIV prevalence was low among wealthy men and women compared to the 
poor [72]. This study underscores yet again that knowledge of HIV prevention alone is not protective 
against acquiring HIV, even during pregnancy. As in the general population (Dunkle et al. [insert 
reference]), it may be difficult for pregnant women financially dependent on their partners to apply 
their knowledge, exercise control over their sex life and negotiate for safe sex, thus placing themselves 
at greater risk of acquiring HIV [62].  
To help prevent new infections in all women, including the pregnant, there is need to empower girls by 
ensuring that their education goes beyond primary level. According to UNFPA [73], “Investing in girls’ 
education is one of the most effective ways to reduce poverty”. Achieving universal primary education 
for all is one of the millennium development goals (MDGs) and attaining this goal will have an impact in 
all MDGs including reduction of new HIV infections [74]. In Swaziland the proportion of women who 
obtained education higher than secondary school level is five percent which is very low [7]. There is 
need for the Government of Swaziland to ensure that education is available and accessible to girls at 
secondary and tertiary levels. Retaining a girl child at school for longer duration may contribute 
significantly to the reduction of HIV acquisition because each year a girl child stays in schools she gains 
greater independence and becomes empowered to make decisions regarding her sexual life [63, 75-78]. 
Another demographic risk factor seen to be associated with seroconversion among pregnant women in 
this study was age. The majority of seroconvertors were below the age of 24 years. Similar findings 
among pregnant women have been reported in previous studies done in Zimbabwe [46, 79].In these 
studies most seroconvertors were below 25 years of age.  
The results deviate with findings on HIV acquisition in the general population. According to the SDHS [7] 
the prevalence of HIV is highest among women aged 25-29 years at 49% and 45% in men aged 35-39 
years. The Swaziland antenatal seroprevalence survey of 2010 showed that HIV prevalence was highest 
in women aged 30-34 years [29]. In a cohort study of women in Durban, South Africa, high risk of HIV 
acquisition was reported among the 25-29 year age group [80]. According to the UNAIDS report[81]in 
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sub-Saharan Africa prevalence of HIV among women is highest in the 30-34 age group whilst in men it 
peaks in the late 30s and early 40s. Gregson et al. [82]in Zimbabwe observed a decline in HIV prevalence 
by 49% in women aged 15-24years. Comparing with general population, this present study indicates that 
pregnant women are at high risk of seroconverting during their pregnancy at a younger age.  
Given the seroconversion during pregnancy at a younger age, it is important for programs to target 
young adolescents and intensify preventative messages before they become sexually active. Also at this 
stage values and life decisions begin to be made. According to Gallant et al. [83]targeting women before 
they engage in sexual activities is the key to keeping them HIV negative because protective behaviours 
can be established at this stage rather than having programs later in life that attempts to change 
behaviour. This means the protective behaviours the girls acquire when they are young will benefit them 
later in life, whether pregnant or not. Previous studies[84, 85] have shown that life skills orientation 
programmes at schools are also key to behaviour change and can be implemented in all schools, 
including primary level.  
Partner factors highlighted in this study associated with HIV seroconversion among pregnant women 
include: partner being a frequent traveler; level of education; reported partner HIV status and discussing 
HIV issues with partner. Partners who travel frequently can place the women at risk of getting HIV as 
suggested by the results of this study, especially if they are away from home for several months. 
Previous studies have shown that frequent travelers who are away for longer periods, especially migrant 
workers, are more likely to engage in risky sexual behaviours because they establish other sexual 
networks [68, 79]. It is important that more focus is placed on educating men to practice safe sex and 
use condoms when they travel. The women who reported that their male partners were less educated 
were more likely to seroconvert, because the level of understanding the risk could be low and they 
might have limited access to knowledge on HIV [21].  
 
Women who reported that their partners were not tested for HIV were at higher risk of acquiring 
infection. Not knowing the partner’s HIV status could result in couples not knowing they are in a 
serodiscordant relationship.   It has been reported in several studies [86-88] that men generally are not 
keen to test for HIV because they see themselves as healthy, others are afraid of a positive result and 
others are afraid of stigma. Furthermore, men are reported to use the women’s HIV results as proxy for 
their own status, thus assuming they are negative if their partner tests negative at initiation of ANC. It is 
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important to ensure men get tested by bringing HIV services closer to them, especially in their 
workplace and recreational places [89, 90]. A study by Yeganeh et al. [91]demonstrated that women 
who had tested for HIV reported that their partners had tested too. However, in this study it was noted 
that all the women knew their status but only two thirds knew the partner’s HIV status.  
Despite the women having access to knowledge on the importance of testing for HIV especially during 
pregnancy, partner testing is still a challenge. There is need to intensify male involvement efforts 
especially during ANC visits, so as to increase the number of partners who know their status [92-94].ANC 
provides an opportunity to reach out to the men when a woman is pregnant compared to the non-
pregnant women. Pre exposure prophylaxis for HIV should be made available in resource-limited areas 
with high HIV prevalence for pregnant women whose partners refuse HIV testing or who have an 
unknown HIV-status, so as to protect the pregnant women from acquiring new infections unknowingly 
and seroconverting during the pregnancy. 
In this study women who reported that their partners were not faithful were more likely to seroconvert 
during pregnancy. A study conducted in Zimbabwe [45,46] yielded similar results:  pregnant women who 
reported partner infidelity were four times more likely to seroconvert during pregnancy or postnatally. 
In a recent study in Malawi on sexual behaviours during pregnancy, the researchers reported that the 
women verbalized that they were concerned that their partners are not faithful when they are pregnant 
and this could increase their chances of acquiring HIV [16]. According to Smith and Watkins women and 
men in general worry about HIV infection from their partners if there is infidelity [95]. 
More than 75% of the women who participated in this study reported that they discussed HIV issues 
with their partners. Studies have shown that when women discuss HIV issues in their relationships, it 
becomes easier for them to bring their partners for testing [91]. Another study showed that women who 
were in concurrent multiple relationships had difficulty in discussing HIV issues especially around 
condom usage [96].In the general population, researchers reported that in a relationship where there is 
no communication on HIV issues, condom usage was less frequent [97].  
This shows that being in a relationship where HIV issues are not discussed puts all women, including 
those pregnant, at risk of acquiring HIV. This could be due to the fact that risk reduction strategies 
cannot be discussed freely in that relationship. If HIV issues are not discussed in the relationship, this 
makes it difficult for pregnant women to put the HIV prevention knowledge acquired during counseling 
into practice.  
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Culture might be a hindrance, preventing women from discussion sexual and HIV issues with their 
partners. Men may feel undermined if women are the ones starting conversations on sexual issues. 
However, women can be empowered to initiate the discussions in the relationship. The ANC setting 
provides health care workers more opportunity at each visit to equip the pregnant women with 
communication skills that will improve their ability to negotiate condom usage compared to the non-
pregnant counterparts. Sexual communication is very important for PMTCT to be effective and it may be 
the key to men changing their sexual behaviours [94, 98-100]. According to Peltzer et al. [101] male 
involvement may influence and reduce risk of HIV acquisition among HIV negative women. Sexual 
communication especially relating to HIV issues might be a challenge. Women might be afraid to talk 
about HIV with their partner for fear of physical abuse because the partner might suspect the woman is 
suspicious of their infidelity. One study highlights that it is easier to discuss HIV issues in stable 
relationships, especially among those who are married and those living with partners [91]. Being 
married however does not mean the women are safe from acquiring HIV, as has been shown indifferent 
studies. In this study, despite the majority of women not being married or living with partners, women 
reported discussing HIV issues in their relationship. This could mean that women perceived their 
relationships to be stable and solid.  
Sexual behaviours and associated factors were assessed in this study. This study demonstrated that 
sexual risk behaviours were observed among pregnant women and they include: multiple partners; 
concurrent and lifetime, unsafe sex, early sexual debut and history of STI. Other studies have also shown 
that pregnant women continue to engage in risky sexual behaviours [5, 13, 16, 40, 91]. The results of the 
study concur with findings on HIV acquisition in general population as shown by different researchers 
[65, 80].  Women who reported more than one partner in the past twelve months were at greater risk of 
acquiring HIV.  The pregnant women might engage in concurrent relationships so that they are able to 
survive by having a partner who will buy food, another for paying rent and another for luxurious gifts. 
Karim et al. [102] argue that poorer women enter into a series of monogamous relationships for their 
own survival and that of their offspring.  
Women might get pregnant to ensure financial support from the father of the child, even after a 
separation and as a result some of them have children from different fathers. A study by Jewkes et al. 
[103]showed that to get financial support a woman can continue to have sex with the father of one or 
more of her children even when they have separated. This study yielded similar results as previous 
studies and showed that women whose children were from different fathers had increased risk of 
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acquiring HIV[46]. According to Dunkle et al. [56] pregnant women who reported they had transactional 
sex were more likely to be HIV seropositive. The women may have greater chances of acquiring HIV 
because they are concerned with getting money and will be ignorant about protecting themselves in the 
process, as long as they survive.  
Having children with different fathers may also be a strong indication that women had more than one 
lifetime partner as shown by the results of the study with whom they engaged in risky sexual activities 
thus exposing themselves to HIV. Multiple serial partners may relate to the aforementioned financial 
dependence on men, which may pose a barrier to women’s capability of practicing the HIV prevention 
knowledge they acquired during counseling at the health facilities [68]. There is need to have 
socioeconomic development programs in place especially at community level to ensure women are 
empowered to fend for themselves. 
Early sexual debut is one of the sexual factors shown by this study to be associated with HIV 
seroconversion. The findings of this study concur with other studies that reported association between 
early sexual debut and high HIV prevalence among the youth because they may not be biologically or 
mentally mature for sex [104, 105]. According to Wand and Ramjee [106] early sexual debut was 
associated with increased HIV prevalence and incidence in young people. Researchers argue that 
women who engage in sex early at a young age are more likely to also engage in other risky behaviours 
such as having multiple partners and not using condoms [80, 107, 108]. 
Young women especially adolescents have been reported to be more at risk of acquiring HIV because 
their genitals are immature and are more likely to be injured during sex compared to older women 
[109]. In a study done in Zimbabwe researchers reported that girls who were less than 19 years became 
pregnant and acquired HIV at their sexual debut[21]. Delaying sexual debut is very important in 
reduction of HIV incidence especially among young women. Yotebieng et al. [110]showed that in boys 
when sex is delayed there is 1.44 times likelihood that a condom will be used at debut and this also 
increases the chances it will be used subsequently. 
Unprotected sex is one of the risks for acquiring HIV and this study showed that women who reported 
unprotected sex during pregnancy were at higher risk of HIV seroconversion. Pregnancy usually occurs in 
a relationship where love and trust have been established and most women see condoms as not 
acceptable in such stable relationships.  Wingood and DiClemente [67] state that women who are in 
steady relationships are three to four times likely to never use condoms compared to those with casual 
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partners. The reason why women may not use condoms when they are pregnant is that they view 
condoms as a family planning method and do not see the need to use them because they are already 
pregnant [111].  Condoms generally in most societies are associated with being promiscuous [102], 
hence all women including those that are pregnant will not see themselves at risk.  
Despite most pregnant women undergoing counseling and knowing the risks, condom usage remains a 
major challenge as highlighted by the results of this study. This study shows that the majority of women 
had four ANC visits, which can be seen as an opportunity for intensifying counseling on safe sex 
throughout pregnancy. Also the regular contact with the health care setting helps to increase access to 
condoms for pregnant women compared to general population. There is need for healthcare workers to 
offer condoms to all pregnant women as a part of the package of care so that prevention opportunities 
are not missed. There is need to intensify prevention campaigns and target pregnant women. A recent 
study in South Africa highlights the importance of condom use especially during pregnancy, in a context 
of increased sexual risk behaviours [40]. 
History of STIs was another factor associated with HIV seroconversion. Literature has shown that HIV 
infection is more likely to occur when there is an STI present, especially of the ulcerative or 
inflammatory type [21, 112]. Presence of syphilis or other STI during pregnancy makes the women 
susceptible to HIV because their genital mucosa is damaged and increases their chances of HIV infection 
therefore seroconversion as shown by this study and previous researchers [17].There is need for 
pregnant women to be taught to identify STI early and seek treatment promptly. During ANC, syphilis 
screening is one of the tests done and this allows for early detection compared to non-pregnant 
counterparts who only seek symptomatic treatment. 
Women in this study who attended their first ANC at a late period of gestation of more than 16 weeks 
were more likely to seroconvert. The results concur with the findings of the SDHS [7] that shows that on 
average women book for their initial ANC at 20 weeks or more.  
There is need to work with communities to encourage women to initiate ANC in the first trimester.  
Earlier initiation will provide greater opportunities to emphasize HIV prevention strategies throughout 
pregnancy.  
Importance of early initiation of ANC can be part of health education for all pregnant women so that on 
subsequent pregnancies they can come early for ANC. Women who had one to two children were at 
high risk of acquiring HIV because they might be in stable relationship where issues of trust and love 
- 43 - 
 
makes it difficult to practice safe sex as they see the condom fit for people who are not in serious 
relationship [102]. 
One of the limitations of this study is that it included sensitive questions on sexual practices to which the 
participants might have not wanted to divulge full information, as the questionnaire was interviewer 
administered. However, the interview was conducted in a private place so as to facilitate the 
participants to answer openly and freely the questions. The study was conducted in a low-income 
mission hospital and this might limit generalization of the findings of this study to other settings like 
private hospitals, as the women might have different characteristics compared to those delivering at 
RFM. However, the central location of RFM makes it accessible to all the four regions of the country 
making possible that a fair representative sample of the general population of pregnant women in 
Swaziland. 
HIV seroconversion during pregnancy remains a major challenge for PMTCT programs especially in 
countries of high prevalence. This means that PMTCT programs require interventions that are able to 
keep HIV negative women free of HIV throughout pregnancy and lactation periods. Most PMTCT 
interventions for a long time have focused on women already living with HIV and little attention has 
been given to women who are HIV negative. Recent studies have shown an increase in incidence of HIV 
among pregnant women. This study focused on HIV seroconversion with the particular aim of 
determining the factors associated with HIV seroconversion during pregnancy. In the absence of any 
studies on HIV seroconversion in Swaziland, a cross-sectional study design facilitated the collection of 
data, which provided the factors associated with HIV seroconversion.   
The results of the study show that despite the women having adequate knowledge on HIV issues, they 
continue to engage in unprotected sex. Counseling on preventative measures especially condom use 
should be strengthened throughout the ANC visits. There is need for PMTCT programs especially in high 
prevalence settings like Swaziland to explore the possibility of providing pre exposure ARVs prophylaxis 
during pregnancy so as to reduce new HIV infections among pregnant women. Understanding how these 
factors interact to lead to HIV seroconversion is very important; as this will help programs provide 
interventions that target all the factors holistically. 
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Appendix A: Administered questionnaire 
 
Study Number__ __ 
Section A: Demographics 
I’d like to start the interview with some questions about you and your family. 
1. What is your age: __ __ (years) 
2. What is your date of birth: __ __ / __ __ / __ __ __ __ (dd-mm-yyyy) 
3. What is your marital status?   
(1) Married    
 (2)Never married / not living with a partner   
(3)Separated 
(4)Widowed 
(5) Divorced    
 (6) Living with partner     
  
4. Is your marriage a polygamous one?          (1) Yes                     (2) No 
 
5. What is the highest level of education you completed at school? 
(1) Some primary   (4) Completed secondary 
(2) Completed primary  (5) Higher education 
(3) Some secondary   (6) Never attended school 
 
6. What do you do earn money?................................................................... 
7. What is your monthly income? 
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(1) none 
(2) Less than E1000 
(3) E1000-3000 
(4) 3000-5000 
(5) 5000 or more 
8. How many times have you been pregnant?  
 
9. How many children are alive?  
 
Section B: Relationship History 
10. What is the level of education of your partner? 
(1) Some primary 
(2) Completed primary 
(3) Some secondary 
(4) Completed secondary 
(5) Higher education 
(6) Never attended school 
11. Is your partner a frequent traveler? 
(1) Yes (if yes, go to question 12)      
(2) No (if no, go to question 14) 
 
12. How often is your partner away from home? 
 (1)Once a week 
 (2) Once a month 
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(3) Every three months 
(4) Every six months 
(5) Once a year 
 
13. How long is your partner away from home? 
 (1) a few days  
 (2) a week at a time 
(3) a month 
 (4) severalmonths 
14. Has your partner tested for HIV? 
(1) Yes                         (2) No                             (3) Don’t know 
15. What is the HIV status of your partner? 
                     (1) Positive      
                     (2)Negative 
                     (3)Don’t know 
16. Is your partner circumcised? 
(1) Yes 
(2) No 
17. Do you think your partner is faithful to you? 
(1) Yes 
(2) No 
(3) Do not know 
 
18. Have you ever been sexually abused?           (1) Yes           (2) No 
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Section C: Sexual behavior 
19. Did you use intravaginal herbs during pregnancy? 
        (1) Yes         
         (2) No 
20. At what age did you have your first sex act?      
21. Did you use a condom at your first sexual encounter?           (1) Yes            (2) No 
22. Have you ever used condoms? 
(1) Yes 
(2) No 
23. Did you use condoms during pregnancy?  
 (1) Yes (If yes, go to question 24)              
 (2) No (if no, go to question 25) 
(3) Abstained from sex (go to question 25) 
24. How often did you use condoms? 
(1) Always 
(2) Sometimes 
25. How many partners have you had in the past year?        
26. How many sexual partners have you had in your lifetime? 
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Section D: Knowledge factors associated with acquisition of HIV 
28. How did you rate your chances of acquiring HIV 
(1) No risk 
(2) Small risk 
(3) Moderate risk 
(4) High risk 
        (5) Don’t know 
29. Did you think you were at risk at the time of, your first HIV test? 
(1) Yes(if answer is yes, go to question 31) 
(2) No (if answer is no, go to question 30) 
 
30. If you do not think you were not at risk, why did you think you were not at risk? 
     (1) I am married 
  (2)I have one sexual partner 
   (3)My partner is faithful 
 (4)I use condoms consistently 
     (5)My partner is circumcised 
    (6)Others 
    (7)Not applicable 
31. To prevent STI/HIV, condoms should be used when? 
         (1)At every sexual encounter 
 (2)At most sexual encounter 
(3)At high risk encounters 
32. Can you always tell if someone is living with HIV? 
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(1) Yes (always show signs) 
(2) No ( can look healthy) 
(3) Do not know 
33. Can a healthy looking man transmit HIV? 
(1) Yes 
(2) No 
(3) Do not know 
34. Can a woman living with HIV transmit HIV to her baby? 
(1) Yes          
(2) No 
(3) Do not know 
35. Can a HIV non-infected woman become HIV positive during pregnancy? 
(1) Yes 
(2) No 
(3) Do not know 
36. Do you talk about HIV with your partner?  
  (1)Yes 
 (2)No 
 
Thank you for participating in the study. 
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Appendix B: Checklist/ Data extraction Tool 
 
1. Parity of the woman…………………………………………………. 
2. Gravida of the woman……………………………………………….. 
3. Number of ANC visits during pregnancy…………………………… 
4. Gestational age at first ANC............................................................... 
5. Was HIV testing done at first ANC visit? 
(1) Yes (if answer is yes, go to number 7) 
(2) No (if  answer is no, go to number 6) 
 
6. At which visit was test eventually offered? 
(1) Second visit 
(2) Third or fourth visit 
 
7. What was the gestational age at first HIV test?.................................  
 
8. Was HIV result given same day of testing? 
                   (1)Yes                            (2) No 
9. Was retesting done at ANC? 
(1) Yes, if yes proceed to number 9 
(2) No, proceed to number 11 
 
10. Gestational age at retest……………………………………………. 
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13. Second HIV test result 
              (1) Reactive         (2) Non-reactive          (3) Inconclusive 
14. RPR result                
         (1) Reactive                 (2) Non-reactive 
 




16. Partner HIV status 
(1) Reactive               (2) Non-reactive            (3) Not tested 
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Appendix C: University of KwaZulu-Natal Biomedical Research Ethics Committee 
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Appendix F: Information document 
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Title of study: Factors associated with HIV Seroconversion during pregnancy in Swaziland, in 2011 
Greeting: Good morning/afternoon, how are you? 
Introduction: I, Sibongile Wusumani, am doing a research on seroconversion among pregnant women 
who were initially HIV non-infected. Research is a process to answer a question. In this study I want to 
find out factors that contribute to seroconversion among pregnant women. 
Invitation to participate: I am inviting you to participate in a research study. 
What is involved in this study: The purpose of this research is to find out factors that make pregnant 
women who were initially HIV non-infected become HIV positive. We will be interviewing all pregnant 
women who were initially HIV non-infected. We will sample 344 pregnant women. Information will be 
collected through an interview which will last about 30-45minutes. We will ask questions about you, 
your relationship history and sexual behavior issues. Your responses will be written on paper by the 
interviewer. 
What are the possible risks: This is a verbal interview with no physical risks. However some of the 
questions may be sensitive; this may result in psychologically/ emotionally distress. If this occurs you will 
be provided with counseling.  
Potential benefits: There are no direct benefits to you for taking part in the study. You will have the 
opportunity to share your views and experiences. The results will be used to help other pregnant 
women to remain HIV negative.  
Participation is entirely voluntary: refusal to participate will not result in penalty and you may 
discontinue the study at any time, without penalty.  
Confidentiality: interviews will take place in a private place. All information given during the interview 
will be kept confidential. Absolute confidentiality cannot be guaranteed; organizations such as the 
Biomedical Research Ethics may inspect your research records for quality assurance and data analysis. 
Questions: if you have any questions about the research contact the principal investigator on 76269590. 
Reporting complaints/problems and questions about your rights as a participant: if you have any 
questions or concerns regarding your rights as a research participant you may contact the Biomedical 
Ethics Research Office, UKZN, Private Bag X54001, Durban 4000. 
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Telephone: 0027 (0) 31 260 4769/ 260 1074 
Fax: 0027 (0) 31 260 4609 
Email: BREC@ukzn.ac.za 
Swaziland National Ethics Committee on 2404 7712, contact person Sisi Lukhele. 
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Appendix G: Informed Consent 
 
Study number_ _ _ _                                           
Consent to participate in Research 
Greetings: Good morning/afternoon. How are you? 
Principal investigator: Sibongile Wusumani 
Title of Study: Factors associated with HIV Seroconversion during pregnancy in Swaziland, in 2011 
You have been asked to participate in a research study to learn more about factors that contribute to 
seroconversion of HIV among pregnant women. 
You have been informed about the study by………………………………… . 
You may contact Sibongile Wusumani at 7626 9590 anytime if you have any questions about the 
research. 
You may contact the Biomedical Ethics Research Office on 0027 (0) 31 260 4769 or 260 1074 or Email: 
BREC@ukzn.ac.za  or Swaziland National Ethics Committee on 2404 7712 if you have any questions 
about your rights as a participant. 
Your participation in this research is not forced. You may refuse or decide to stop participation in this 
study at any time for any reason. This will not affect your future care at this health facility or with your 
nurse or doctor.   
 The details of the research study and the above information have been described to me orally. I have 
understood this information and I agree to participate in this study in my free will. I have been given 
time to ask questions that l might have about participation in this research. 
 
Signature/ Thumb of Participant                   Date 
 
Signature of witness         Date 
